Skip to main content
Clinical Trials/CTRI/2023/08/056032
CTRI/2023/08/056032
Recruiting
Phase 2

Comparison of efficacy of back school program versus supervised physical therapy exercise program on the pain, disability, lumbar spine mobility and back muscle endurance of patients with chronic non-specific low-back pain: a randomized controlled trial. - Not applicable

Himanshu Pathak0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M999- Biomechanical lesion, unspecified
Sponsor
Himanshu Pathak
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Himanshu Pathak

Eligibility Criteria

Inclusion Criteria

  • 1\.The study will include patients aged 18 to 65 years diagnosed with chronic non\-specific low back
  • pain, defined as pain in the back, located between the last rib and the gluteal fold, with mechanical
  • characteristics lasting more than 3 months.
  • 2 Patients with Self\-rated pain with an intensity of \>20 mm on the visual analogue scale for pain will be included in the study.
  • 3\. Patients with mild VAS score \= 3\.4 cm corresponds best with mild pain and moderate VAS score 3\.5 to 7\.4 cm with moderate pain will be included in the study.
  • 4\. Patients with a score of 14% or more on the Oswestry Disability Index (ODI), Independently mobile (with or without aids) to be capable of participating in a rehabilitation programme,will be included in the study.

Exclusion Criteria

  • 1\.Patients having primary pain area other than the lower back (from T12 to buttocks), leg pain as the
  • primary problem (eg, nerve root compression or disc prolapse with true radicular
  • pain/radiculopathy, lateral recess or central spinal stenosis)will be excluded.
  • 2\.Patients having Lumbar spine, lower limb or abdominal surgery in previous 6 months will be excluded.
  • 3\.Patients Having undergone pain\-relieving procedures such as injection\-based therapy (eg, epidurals) and
  • day care procedures (eg, rhizotomy) in the last 3months will be excluded.
  • 4\.Patients with Pregnancy, rheumatological/inflammatory disease (eg, rheumatoid arthritis, ankylosing
  • spondylitis, psoriatic arthritis, lupus erythematosus, Scheuermann’s disease).
  • Progressive neurological disease (eg, multiple sclerosis, Parkinson’s disease, motor neuron
  • disease)will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials